James Rolke

This profile gathers the share dealings of James Rolke across 2 companies, led by La Jolla Pharmaceutical Co and Revelation Biosciences, Inc. The record holds 47 filings, for trades running from 16 August 2018 to 17 August 2026.

On the market, this insider has only ever bought: 4 purchases, €28k in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 43 share grants.

In size, the median ticket on the buying side is €3,459. On 4 out of 4 purchases, another insider of the same company was buying within the same 30 days. Purchases made close together by different insiders form what is called a cluster.

The record was last updated on 18 August 2026 with a share grant in Revelation Biosciences, Inc. The last purchase on record was published on 9 January 2019, which is 2,845 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.